title: Short-term continuous infusion of octreotide in acromegaly. Pharmacokinetics and prediction of the response to long-term treatment.
authors.affiliation: Department of Internal Medicine, Hôpital Lariboisière, Paris, France.
authors.forename: J
authors.initials: J
authors.lastname: Timsit
authors.forename: P
authors.initials: P
authors.lastname: Chanson
authors.forename: A G
authors.initials: AG
authors.lastname: Harris
authors.forename: P
authors.initials: P
authors.lastname: Grass
authors.forename: P J
authors.initials: PJ
authors.lastname: Guillausseau
authors.forename: A
authors.initials: A
authors.lastname: Warnet
authors.forename: J
authors.initials: J
authors.lastname: Lubetzki
mesh_terms: D000172:Acromegaly / Q000097:blood / Q000188:drug therapy*; D000293:Adolescent; D000328:Adult; D005260:Female; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*
chemical_list: D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone; D015282:Octreotide